Research has indicated that patients with advanced hepatocellular (or liver) cancer have high mortality rates as existing drugs confer only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data from human tumors, researchers from the Icahn School of Medicine at Mount Sinai hope to identify potential genes of interest that can be targeted for new treatments for hepatocellular carcinoma, the most common form of liver ...
Read More
You have just read an article categorized health
titled UHRF1 is the Oncogene Driving Liver Cancer, Say Mount Sinai Researchers.
Written by:
editor -
Sunday, February 2, 2014
There are currently no comments for "UHRF1 is the Oncogene Driving Liver Cancer, Say Mount Sinai Researchers"
Post a Comment